|Written by GSCR Staff|
|Thursday, 17 January 2013 12:21|
Maybe it’s me, but I cannot get enough of the Herbalife (NYSE – HLF - $45.06) story. Hopefully you are just as entertained. Yesterday, M&A raider and noted aggressive activist investor Carl Icahn bought a small stake in HLF, and the shares rose. The Company beat Street earnings estimates and the stock appears to still be mired in a game of tug-of-war. Will the ‘shorts’ get revenge soon? Here are 5 reasons I think the story has some legs and will continue to appear in the news for the next several months.
1) Drama Sells
No matter how much even we the industry like to pretend we are about ‘numbers’, these types of stories always get our interest. CNBC, Bloomberg, FOX Business as well as all the online and paper media outlets continue to cover this. This stuff always gets ratings.
2) Giant Egos
Let’s face it, Icahn, Loeb, and Ackman all have giant egos. Like any super-successful pro-athlete or Hollywood superstar, fame is part of the reason for their fortune. I would not be surprised to see more marquee names to jump into this battle on both sides
3) The Industry
We have a serious weight problem as a nation. The ‘all-natural’ approach is a hot industry in general, so it is definitely topical. The story would probably lose steam if we were talking about hydraulic valves. What are those? Exactly
4) Analysts Analyze
When Ackman said that HLF was a ‘Ponzi’ scheme it stimulated the interest of the entire independent analyst community to dig into the books. Sites like Seeking Alpha have been bombarded with everyone’s two cents. At last check, there are close to 30 articles since January 1st from various analysts with grand ‘one-upsmanship’ in headlines like “Herbalife: Hedge Fund Porn, Part II.”
5) Economics Concern? Enough Already
At this point even with a debt ceiling deadline looming this ‘drama’ is losing steam. There is no doubt that it will heighten the closer we get, but more than likely a deal will be completed at the last minute. After that, what else is there for media to sensationalize?
For now, we think the ‘longs’ win and the stock ultimately climbs a bumpy ride up back to its 52-week high near $70.
Have a great day!
Disclosure: Goldman Small Cap Research analysts are neither long nor short these shares but may elect to purchase the stock within the next 48 hours.
This Market Monitor blog was prepared for informational purposes only. Goldman Small Cap Research, (a division of Two Triangle Consulting Group, LLC) produces research via two formats: Goldman Select Research, which typically highlights small cap companies, and Goldman Opportunity Research, which features micro cap companies in a sponsored research format. Thus, the Select product reflects the Firm’s internally generated stock ideas while the Opportunity product reflects sponsored research reports.
It is important to note that while we may track performance separately, we utilize the same coverage criteria in determining coverage of all stocks in both research formats. Please view the company’s individual disclosures for each engagement, which can be found in each company-specific report. All information contained in this blog, newsletter and in our reports were provided by the Companies or generated from our own due diligence. Our analysts are responsible only to the public, and are paid in advance to eliminate pecuniary interests, retain editorial control, and ensure independence. Analysts are compensated on a per report basis and not on the basis of his/her recommendations.
The information used and statements of fact made have been obtained from sources considered reliable but we neither guarantee nor represent the completeness or accuracy. Goldman Small Cap Research did not make an independent investigation or inquiry as to the accuracy of any information provided by the Company, or other firms. Goldman Small Cap Research relied solely upon information provided by the Company through its filings, press releases, presentations, and through its own internal due diligence for accuracy and completeness. Such information and the opinions expressed are subject to change without notice. A Goldman Small Cap Research blog, report, note, or newsletter is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed.
This blog does not take into account the investment objectives, financial situation, or particular needs of any particular person. This blog does not provide all information material to an investor’s decision about whether or not to make any investment. Any discussion of risks in this presentation is not a disclosure of all risks or a complete discussion of the risks mentioned. Neither Goldman Small Cap Research, nor its parent, is registered as a securities broker-dealer or an investment adviser with FINRA or with any state securities regulatory authority.
ALL INFORMATION IN THIS BLOG, REPORT OR NEWSLETTER IS PROVIDED “AS IS” WITHOUT WARRANTIES, EXPRESSED OR IMPLIED, OR REPRESENTATIONS OF ANY KIND. TO THE FULLEST EXTENT PERMISSIBLE UNDER APPLICABLE LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE FOR THE QUALITY, ACCURACY, COMPLETENESS, RELIABILITY OR TIMELINESS OF THIS INFORMATION, OR FOR ANY DIRECT, INDIRECT, CONSEQUENTIAL, INCIDENTAL, SPECIAL OR PUNITIVE DAMAGES THAT MAY ARISE OUT OF THE USE OF THIS INFORMATION BY YOU OR ANYONE ELSE (INCLUDING, BUT NOT LIMITED TO, LOST PROFITS, LOSS OF OPPORTUNITIES, TRADING LOSSES, AND DAMAGES THAT MAY RESULT FROM ANY INACCURACY OR INCOMPLETENESS OF THIS INFORMATION). TO THE FULLEST EXTENT PERMITTED BY LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE TO YOU OR ANYONE ELSE UNDER ANY TORT, CONTRACT, NEGLIGENCE, STRICT LIABILITY, PRODUCTS LIABILITY, OR OTHER THEORY WITH RESPECT TO THIS PRESENTATION OF INFORMATION.
For more information, visit our Disclaimer: www.goldmanresearch.com